Help is a stem cell regeneration R&D organization that uses iPSC technologies to develop universal cell therapy products.
Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center, leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 15, 2021 | Series C | $25M | 1 | — | — | Detail |
May 5, 2019 | Series A | — | 2 | Yongchuang Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Yongchuang Capital | Yes | Series A |
Purple Bull Startups | — | Series C |
Lead Wealth Capital | — | Series A |